{
    "clinical_study": {
        "@rank": "67266", 
        "arm_group": [
            {
                "arm_group_label": "Antibiotic Prophylaxis", 
                "description": "This cohort will receive antibiotic prophylaxis prior to the hernia repair"
            }, 
            {
                "arm_group_label": "No Antibiotic Prophylaxis", 
                "description": "This cohort will not receive antibiotic prophylaxis prior to the surgery"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to find out whether it is necessary to prophylactically treat\n      patients undergoing laparoscopic inguinal hernia repairs with antibiotics. Our hypothesis is\n      that it is not necessary to pretreat patients with antibiotics if the operation is minimally\n      invasive with a mesh placed at the defect."
        }, 
        "brief_title": "Prophylactic Antibiotic Treatment for Laparoscopic Inguinal Hernia Mesh Repair: Necessary or Not?", 
        "completion_date": {
            "#text": "April 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Hernia, Inguinal", 
        "condition_browse": {
            "mesh_term": [
                "Hernia", 
                "Hernia, Inguinal"
            ]
        }, 
        "detailed_description": {
            "textblock": "The investigators plan to follow up at least 100 patients who did not receive antibiotics\n      prior to their inguinal hernia repair and compare their outcome to 100 patients who did\n      receive prophylaxis. The investigators mainly will be analyzing the incidence of surgical\n      site infections as evidenced by swelling, redness, pain, warmth or other signs deemed by the\n      surgeon."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Elective laparoscopic inguinal hernia repair, unilateral or bilateral\n\n        Exclusion Criteria:\n\n          -  Those requiring antibiotics for the surgery;\n\n          -  Those patients who have experienced surgical site infections from previous surgeries"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "100 patients undergoing elective hernia repair will be assigned randomly to the control\n        group; 100 patients will be assigned to the treatment group."
            }
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 8, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02083939", 
            "org_study_id": "SHEBA-12-9550-DR-CTIL"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Bacterial Agents", 
                "Antibiotics, Antitubercular"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Inguinal hernia", 
            "Mesh repair", 
            "Prophylactic Antibiotics", 
            "Herniorrhaphy", 
            "Laparoscopic Inguinal Hernia Repair"
        ], 
        "lastchanged_date": "March 13, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tel Hashomer", 
                    "country": "Israel"
                }, 
                "name": "Sheba Medical Center"
            }
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_groups": "2", 
        "official_title": "Prophylactic Antibiotic Treatment for Laparoscopic Inguinal Hernia Mesh Repair: Necessary or Not?", 
        "overall_official": {
            "affiliation": "Sheba Medical Center", 
            "last_name": "Danny Rosin, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The investigators will interview the patient at one week, at one month, and at one year post-operation and assess for any signs of infection around the location of hernia repair.", 
            "measure": "Incidence of surgical site infection", 
            "safety_issue": "Yes", 
            "time_frame": "One year post-operation"
        }, 
        "reference": [
            {
                "PMID": "23052809", 
                "citation": "Cabaluna ND, Uy GB, Galicia RM, Cortez SC, Yray MD, Buckley BS. A randomized, double-blinded placebo-controlled clinical trial of the routine use of preoperative antibiotic prophylaxis in modified radical mastectomy. World J Surg. 2013 Jan;37(1):59-66. doi: 10.1007/s00268-012-1816-5."
            }, 
            {
                "PMID": "23063084", 
                "citation": "Shah JN, Maharjan SB, Paudyal S. Routine use of antibiotic prophylaxis in low-risk laparoscopic cholecystectomy is unnecessary: a randomized clinical trial. Asian J Surg. 2012 Oct;35(4):136-9. doi: 10.1016/j.asjsur.2012.06.011. Epub 2012 Aug 22."
            }, 
            {
                "PMID": "24120711", 
                "citation": "Wang J, Ji G, Yang Z, Xi M, Wu Y, Zhao P, Wang L, Yu W, Wen A. Prospective randomized, double-blind, placebo controlled trial to evaluate infection prevention in adult patients after tension-free inguinal hernia repair. Int J Clin Pharmacol Ther. 2013 Dec;51(12):924-31. doi: 10.5414/CP201877."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02083939"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Sheba Medical Center", 
            "investigator_full_name": "Dr. Danny Rosin, MD", 
            "investigator_title": "Attending Surgeon", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Sheba Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sheba Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}